Home/Filings/4/0001140361-17-029589
4//SEC Filing

Andrews Timothy K. 4

Accession 0001140361-17-029589

CIK 0001656328other

Filed

Jul 31, 8:00 PM ET

Accepted

Aug 1, 4:19 PM ET

Size

5.8 KB

Accession

0001140361-17-029589

Insider Transaction Report

Form 4
Period: 2017-08-01
Andrews Timothy K.
General Counsel & Secretary
Transactions
  • Purchase

    Common Stock

    2017-08-01$15.00/sh+15,000$225,00015,000 total(indirect: See Footnote)
Holdings
  • Common Stock

    51,737
Footnotes (2)
  • [F1]The Reporting Person purchased the shares of the Issuer's common stock in connection with the Issuer's initial public offering at the offering price of $15.00 per share.
  • [F2]The shares are directly held by Steelhead Bioventures LLC, a limited liability company in which the Reporting Person holds a controlling interest.

Documents

1 file

Issuer

Sienna Biopharmaceuticals, Inc.

CIK 0001656328

Entity typeother

Related Parties

1
  • filerCIK 0001711464

Filing Metadata

Form type
4
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 4:19 PM ET
Size
5.8 KB